According to a 2022 study in the journal Diabetes, Obesity and Metabolism that followed 327 people after they quit taking semaglutide (the generic name of Ozempic) injections, ongoing treatment is required to maintain improvements in weight or health.4 In other words, these are drugs that people will need to take for their lifetime in order to maintain successful results
Conagra, the first US food manufacturer to introduce GLP-1 Friendly verbiage on its packaging, is marketing six additional meals this year that feature a GLP-1 Friendly badge, according to company spokesperson Dan Hare
Studies have shown that berberine may be used to replace metformin, at least partially
No needles increased accessibility and adherence Double strength means fewer adjustments and stronger response early on Same therapeutic exposure as injections for a fraction of the cost Consistent flat monthly price of $250 Fast delivery across Arkansas (48-hour turnaround)
These studies suggest retatrutide is one of the most promising obesity and diabetes treatments currently in development
